SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019293
Filing Date
2022-05-10
Accepted
2022-05-10 16:22:20
Documents
52
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20220331.htm   iXBRL 10-Q 1920745
2 EX-10.3 life-ex103_191.htm EX-10.3 183339
3 EX-10.4 life-ex104_190.htm EX-10.4 83607
4 EX-31.1 life-ex311_7.htm EX-31.1 9824
5 EX-31.2 life-ex312_6.htm EX-31.2 9871
6 EX-32.1 life-ex321_8.htm EX-32.1 6313
7 EX-32.2 life-ex322_9.htm EX-32.2 6164
  Complete submission text file 0001564590-22-019293.txt   6568197

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA life-20220331.xsd EX-101.SCH 38459
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20220331_cal.xml EX-101.CAL 38945
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20220331_def.xml EX-101.DEF 137085
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20220331_lab.xml EX-101.LAB 313580
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20220331_pre.xml EX-101.PRE 238522
46 EXTRACTED XBRL INSTANCE DOCUMENT life-10q_20220331_htm.xml XML 1095749
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 22910003
SIC: 2836 Biological Products, (No Diagnostic Substances)